News

David Mintz Appointed Chair of Anesthesiology at UM School

David Mintz Appointed Chair of Anesthesiology at UM School

David Mintz Takes Charge of Anesthesiology at UM School of Medicine

In a remarkable development for the University of Maryland School of Medicine, D. Mintz, MD, PhD, known for his outstanding contributions as an anesthesiology physician-scientist and operations leader, has been appointed as the Chair of the Department of Anesthesiology. This decision highlights the institution's commitment to enhancing the quality of medical education and patient care.

Extensive Background in Anesthesiology

Dr. Mintz comes to this pivotal role after serving as Vice Chair for Clinical Operations at Johns Hopkins Medicine. His efforts managed a broad spectrum of anesthesiology services across multiple facilities, emphasizing a collaborative approach to patient care while improving operational efficiency. With his extensive experience, he brings a wealth of knowledge to lead transformative initiatives aimed at enhancing both employee satisfaction and patient outcomes.

Expertise in Neuroanesthesia

As a leading neuroanesthesiologist, Dr. Mintz specializes in complex surgical anesthesia, focusing on procedures related to neurosurgery and neurovascular operations. During his previous role, he played a crucial part in establishing a distinguished fellowship program in neuroanesthesiology, training the next generation of specialists in this vital field. This mentorship demonstrates his dedication to fostering talent and leadership in academic medicine.

Research Contributions and Innovations

A significant aspect of Dr. Mintz's career includes his impressive record as a physician-scientist. He has contributed to over 75 published works and maintained continuous NIH funding for his laboratory over many years. His cutting-edge research focuses on how early exposure to anesthetic agents impacts brain development, crucial findings that resonate within pediatric care and intensive medicine. By serving as an Associate Editor for one of the leading journals in the field, Dr. Mintz continues to influence anesthesiology education and practice at a national level.

Diverse Leadership Role

In addition to leading the anesthesiology department, Dr. Mintz will take an active role in advancing initiatives at the University of Maryland Medicine Institute for Neuroscience Discovery, collaborating on multidisciplinary research projects. His involvement will not only enhance the department's reputation but also contribute to the overarching goal of improving trauma care and anesthetic practices.

Vision for Future Excellence

Dr. Mintz expressed enthusiasm about joining the esteemed faculty and a commitment to building upon the school’s already prestigious history in anesthesiology. His focus will not only be on clinical excellence but also on elevating the journey for learners, ensuring they receive the best training possible. The department already ranks highly in NIH-funded research, indicating the impact Dr. Mintz is anticipated to have.

Support from the Medical Community

Leaders within the school, including Dean Mark T. Gladwin, MD, have praised his appointment, emphasizing Dr. Mintz's potential to drive innovation and foster collaboration among staff. His track record of improving clinical operations is particularly noteworthy, as it aligns with the university's commitment to excellence in patient care.

Looking Forward

Dr. Mintz, who has previously earned awards for his teaching and research efforts, is ready to face the new challenges as he integrates into the Maryland medical community. His personal and professional life reflects a dedication not only to medicine but also to education, underscoring his role in shaping future leaders in the field.

Frequently Asked Questions

Who is David Mintz?

David Mintz is the newly appointed Chair of the Department of Anesthesiology at the University of Maryland School of Medicine, recognized for his expertise and leadership.

What is Dr. Mintz's area of specialization?

He specializes in neuroanesthesiology, focusing on anesthetic management for complex neurosurgical procedures.

What prior experience does Dr. Mintz have?

Dr. Mintz previously served as Vice Chair for Clinical Operations at Johns Hopkins Medicine, overseeing anesthesiology services and improving operational efficiencies.

What are Dr. Mintz's research interests?

His research primarily focuses on the effects of early anesthetic exposure on brain development, contributing significantly to pediatric perioperative medicine research.

What goals does Dr. Mintz have for the Department of Anesthesiology?

He aims to enhance education, drive research initiatives, and improve clinical practices while fostering collaboration across multiple departments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Leviton Ignites Bridgestone Arena's Modern Makeover

Updated Category News Views 36

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 16

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CASEKOO's Spooky Collectibles: Postcards Meet Cases

Updated Category News Views 65

Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...

Continue Reading
Cowfest 2026 Delighted by Frederick's Flying Cows

Updated Category News Views 52

Moo-ving Towards a New Record Alright, listen up. This fall, there's a bovine spectacle coming to Maryland that's more than just a trip down to the fairgrounds—it's Cowfest 2026, baby! Now, if you're scratching your head thinking this is just another seasonal shindig, you're underestimating what's mooing across Frederick County. The Flying Cows are ready to take the...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 23

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Civista Welcomes Healthcare Leader to Boost Growth

Updated Category News Views 122

Expanding the Boardroom with Healthcare Expertise In an unexpected twist for Civista Bancshares (NASDAQ: CIVB), the financial holding company is roping in some healthcare brass to its board. Jeremy Normington-Slay just snagged a seat at Civista's table, and he's bringing his tough-sledding healthcare leadership chops straight from Firelands Health. A $4.3 billion outfit...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 185

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading

Top 5 Most Recently Viewed Articles

Americase Launches Innovative Eco-Friendly Rack Packaging

Updated Category News Views 93

Americase Launches Innovative Eco-Friendly Rack Packaging Americase, a prominent manufacturer specializing in protective containers for hazardous and high-value goods, is making waves in the cloud computing industry with its latest offering: an AI Rack Packaging solution designed to revolutionize how server racks are transported. This groundbreaking solution is not only...

Continue Reading
LEEF Brands Completes Significant Early Convertible Debentures Conversion

Updated Category News Views 151

LEEF Brands Announces Major Milestone LEEF Brands, Inc. (CSE: LEEF) is making headlines with its recent announcement regarding the early conversion of its convertible debentures. This move signifies a robust step forward for the company, supporting its long-term growth initiatives and strengthening its financial position. Details of the Convertible Debentures Conversion...

Continue Reading
Investors of Bitfarms Ltd. May Lead Class Action Lawsuit

Updated Category News Views 130

Important Opportunity for Bitfarms Ltd. Investors Investors who purchased securities of Bitfarms Ltd. (NASDAQ: BITF) during a specific period may have an opportunity to participate in a class action lawsuit concerning alleged securities fraud. Rosen Law Firm, a respected law firm specializing in investor rights, is encouraging affected investors to take action....

Continue Reading
Tom Lee's Vision for Ethereum at BitMine Immersion Technologies

Updated Category News Views 414

Tom Lee’s Ambitious Plans for BitMine Tom Lee, the well-known Wall Street veteran and co-founder of Fundstrat, is diving into the Ethereum world with plans to convert BitMine Immersion Technologies into a leading player in the Ethereum market. His vision is to reshape BitMine, previously known for Bitcoin mining, into what he describes as the 'MicroStrategy of...

Continue Reading
Frontline Managed Services Expands with Investment from Broad Sky Partners

Updated Category News Views 151

Strategic Investment in Frontline Managed Services Frontline Managed Services, a leading global provider of outsourced solutions specifically tailored for the legal industry, has announced an important strategic investment from Broad Sky Partners. This collaboration aims to leverage Frontline's unique position in the market, where it delivers exceptional Managed IT...

Continue Reading